Zobrazeno 1 - 1
of 1
pro vyhledávání: '"Mazen S. Zenati"'
Autor:
James M. Rossetti, John Lister, Mazen S. Zenati, Haifaa Abdulhaq, Entezam Sahovic, Folefac Atem, Bushra Haq, Joan M. Latsko, Richard K. Shadduck, Rubens Costa
Publikováno v:
Cancer. 117:2690-2696
BACKGROUND: Hypomethylating drugs are useful in the management of myelodysplastic syndrome (MDS). Two of these drugs, azacitidine and decitabine, have received FDA approval for the treatment of MDS and chronic myelomonocytic leukemia (CMML). However,